FDA women’s health appropriations
Executive Summary
Senate Appropriations Committee recommends FDA fund the Office of Women's Health at not less than the current level of $3.075 mil. in FY 2004 Agriculture Appropriations report, the same amount as President Bush's FY 2004 budget request. The House Ag Approps bill recommends a $600,000 increase for the office, primarily to fund a hormone therapy outreach campaign (1"The Pink Sheet" July 7, 2003, In Brief). The Senate approps committee approved its bill July 17 and the full House passed its bill July 14 by a vote of 347-64...
You may also be interested in...
Office of Women’s Health
House Appropriations also recommends FDA's Office of Women's Health dedicate $500,000 "to supporting and implementing important women's health outreach activities, including the hormone replacement education initiative that was started in" FY 2003, the report states. Overall, the committee recommends a $600,000 increase for the office. Commissioner McClellan has said the education effort will stress short-term, low-dose use of hormone replacement therapy (1"The Pink Sheet" March 10, 2003, p. 28)...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.